AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 66 filers reported holding AQUESTIVE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 16.03 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,292 | +325.0% | 783 | +193.3% | 0.00% | – |
| Q1 2023 | $304 | -98.6% | 267 | -98.9% | 0.00% | – |
| Q4 2022 | $21,886 | -37.5% | 24,261 | -19.0% | 0.00% | – |
| Q3 2022 | $35,000 | +25.0% | 29,942 | -32.4% | 0.00% | – |
| Q2 2022 | $28,000 | -79.4% | 44,299 | -15.2% | 0.00% | – |
| Q1 2022 | $136,000 | -54.2% | 52,252 | -31.6% | 0.00% | – |
| Q4 2021 | $297,000 | +330.4% | 76,393 | +382.6% | 0.00% | – |
| Q3 2021 | $69,000 | +23.2% | 15,831 | +13.1% | 0.00% | – |
| Q2 2021 | $56,000 | -58.5% | 13,992 | -46.2% | 0.00% | – |
| Q1 2021 | $135,000 | +13400.0% | 25,989 | +20363.8% | 0.00% | – |
| Q3 2020 | $1,000 | -97.1% | 127 | -98.2% | 0.00% | – |
| Q2 2020 | $34,000 | – | 7,035 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $16,188,081 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 725,208 | $1,196,593 | 3.78% |
| Bracebridge Capital, LLC | 428,571 | $707,142 | 0.39% |
| Latash Investments, LLC | 243,134 | $401,171 | 0.32% |
| XTX Topco Ltd | 138,145 | $227,939 | 0.04% |
| ARMISTICE CAPITAL, LLC | 1,158,000 | $1,910,700 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 84,355 | $139,186 | 0.01% |
| Hillsdale Investment Management Inc. | 66,600 | $109,890 | 0.01% |
| D.B. Root & Company, LLC | 12,950 | $21,368 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 147,856 | $243,962 | 0.01% |